These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10141 related articles for article (PubMed ID: 1830477)

  • 21. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
    Stewart RJ; Fredenburgh JC; Rischke JA; Bajzar L; Weitz JI
    J Biol Chem; 2000 Nov; 275(47):36612-20. PubMed ID: 10970891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen.
    Grailhe P; Nieuwenhuizen W; Anglés-Cano E
    Eur J Biochem; 1994 Feb; 219(3):961-7. PubMed ID: 8112348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator.
    Dodd I; Fears R; Robinson JH
    Thromb Haemost; 1986 Feb; 55(1):94-7. PubMed ID: 3085269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin.
    Higgins DL; Vehar GA
    Biochemistry; 1987 Dec; 26(24):7786-91. PubMed ID: 2962641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
    Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
    Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
    de Munk GA; Caspers MP; Chang GT; Pouwels PH; Enger-Valk BE; Verheijen JH
    Biochemistry; 1989 Sep; 28(18):7318-25. PubMed ID: 2510823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
    Takada A; Takada Y
    Thromb Res; 1989 Sep; 55(6):717-25. PubMed ID: 2551068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the domains of tissue-type plasminogen activator involved in the augmented binding to fibrin after limited digestion with plasmin.
    de Vries C; Veerman H; Pannekoek H
    J Biol Chem; 1989 Jul; 264(21):12604-10. PubMed ID: 2526127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited proteolysis of vitronectin by plasmin destroys heparin binding activity.
    Sane DC; Moser TL; Greenberg CS
    Thromb Haemost; 1991 Sep; 66(3):310-4. PubMed ID: 1720904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin-binding and tissue plasminogen activator catalytic domains.
    Robbins KC; Boreisha IG
    Biochemistry; 1987 Jul; 26(15):4661-7. PubMed ID: 3117104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.
    Fleury V; Loyau S; Lijnen HR; Nieuwenhuizen W; Anglés-Cano E
    Eur J Biochem; 1993 Sep; 216(2):549-56. PubMed ID: 8375393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody interferes with fibrin binding of t-PA.
    Matsuo O; Okada K; Fukao H; Tanaka N; Ueshima S
    Thromb Res; 1988 Sep; 51(5):485-94. PubMed ID: 2459803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
    Soeda S; Kakiki M; Shimeno H; Nagamatsu A
    Biochim Biophys Acta; 1987 Dec; 916(3):279-87. PubMed ID: 3120775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis.
    Weening-Verhoeff EJ; Quax PH; van Leeuwen RT; Rehberg EF; Marotti KR; Verheijen JH
    Protein Eng; 1990 Dec; 4(2):191-8. PubMed ID: 1963688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penta-L-lysine Potentiates Fibrin-Independent Activity of Human Tissue Plasminogen Activator.
    Rehan M; Sagar A; Sharma V; Mishra S; Ashish ; Sahni G
    J Phys Chem B; 2015 Oct; 119(42):13271-7. PubMed ID: 26447340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
    Suenson E; Bjerrum P; Holm A; Lind B; Meldal M; Selmer J; Petersen LC
    J Biol Chem; 1990 Dec; 265(36):22228-37. PubMed ID: 2148318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oxidants on proteases of the fibrinolytic system: possible role for methionine residues in the interaction between tissue type plasminogen activator and fibrin.
    Stief TW; Martín E; Jimenez J; Digón J; Rodriguez JM
    Thromb Res; 1991 Feb; 61(3):191-200. PubMed ID: 1827545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416.
    Petersen LC; Boel E; Johannessen M; Foster D
    Biochemistry; 1990 Apr; 29(14):3451-7. PubMed ID: 2112946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actin accelerates plasmin generation by tissue plasminogen activator.
    Lind SE; Smith CJ
    J Biol Chem; 1991 Sep; 266(26):17673-8. PubMed ID: 1832675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of tissue-plasminogen activator to fibrin: effect of ultrasound.
    Siddiqi F; Odrljin TM; Fay PJ; Cox C; Francis CW
    Blood; 1998 Mar; 91(6):2019-25. PubMed ID: 9490686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 508.